mRNA Vaccines and Therapeutics Market Report

Global mRNA Vaccines and Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Nov 16, 2019
  • PAGES：199
  • REPORT CODE：GMM381890
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The mRNA Vaccines and Therapeutics is expected to grow from USD 3252 million in 2018 to 5895 million by 2025, at a Compound Annual Growth Rate (CAGR) of 8.87% during the forecast period. The research provides insights for the global mRNA Vaccines and Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the mRNA Vaccines and Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global mRNA Vaccines and Therapeutics Market Segmentations:

    By Players:

    • BioNtech

    • eTheRNA immunotherapies

    • BioNTech

    • Bayer

    • Janssen

    • In-Cell-Art

    • MaxCyte

    • CRISPR Therapeutics

    • PhaseRx

    • Kernal Biologics

    • Novartis

    • Precision NanoSystems

    • RaNa Therapeutics

    • CureVac

    • Bayer Group Therapeutics

    • Crispr Therapeutics

    • AstraZeneca

    • Argos Therapeutics

    • AstraZeneca Plc Vaccines

    • Ethris

    By Types:

    • Standardization Of Cancer Treatment mRNA Vaccine

    • Individualized Cancer Treatment mRNA Vaccine

    • Infectious Disease Treatment mRNA Vaccine

    • Infection Prevention mRNA Vaccine

    By End-User:

    • Hospital

    • Clinic

    • Other

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of mRNA Vaccines and Therapeutics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global mRNA Vaccines and Therapeutics Market Share by Types

      • 1.3.2 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine from 2014 to 2026

      • 1.3.3 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment mRNA Vaccine from 2014 to 2026

      • 1.3.4 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease Treatment mRNA Vaccine from 2014 to 2026

      • 1.3.5 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infection Prevention mRNA Vaccine from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global mRNA Vaccines and Therapeutics Market Share by End-Users

      • 1.4.2 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.3 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

      • 1.4.4 Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina mRNA Vaccines and Therapeutics Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of mRNA Vaccines and Therapeutics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of mRNA Vaccines and Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine

      • 3.4.2 Market Size and Growth Rate of Individualized Cancer Treatment mRNA Vaccine

      • 3.4.3 Market Size and Growth Rate of Infectious Disease Treatment mRNA Vaccine

      • 3.4.4 Market Size and Growth Rate of Infection Prevention mRNA Vaccine

    4 Segmentation of mRNA Vaccines and Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of mRNA Vaccines and Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of mRNA Vaccines and Therapeutics for Hospital

      • 4.4.2 Market Size and Growth Rate of mRNA Vaccines and Therapeutics for Clinic

      • 4.4.3 Market Size and Growth Rate of mRNA Vaccines and Therapeutics for Other

    5 Market Analysis by Major Regions

    • 5.1 Global mRNA Vaccines and Therapeutics Production Analysis by Major Regions

    • 5.2 Global mRNA Vaccines and Therapeutics Consumption Analysis by Major Regions

    • 5.3 Global mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

    6 Product Commodity of mRNA Vaccines and Therapeutics Market in Major Countries

    • 6.1 Top 5 Export Countries in mRNA Vaccines and Therapeutics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in mRNA Vaccines and Therapeutics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America mRNA Vaccines and Therapeutics Landscape Analysis

    • 7.1 North America mRNA Vaccines and Therapeutics Landscape Analysis by Major Types

    • 7.2 North America mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users

    • 7.3 North America mRNA Vaccines and Therapeutics Landscape Analysis by Major Countries

      • 7.3.1 United States mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 7.3.2 Canada mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 7.3.3 Mexico mRNA Vaccines and Therapeutics Market Volume and Growth Rate

    8 Europe mRNA Vaccines and Therapeutics Landscape Analysis

    • 8.1 Europe mRNA Vaccines and Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe mRNA Vaccines and Therapeutics Landscape Analysis by Major Countries

      • 8.3.1 Germany mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.3 France mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.6 Spain mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.7 Belgium mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.8 Poland mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.9 Russia mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 8.3.10 Turkey mRNA Vaccines and Therapeutics Market Volume and Growth Rate

    9 Asia Pacific mRNA Vaccines and Therapeutics Landscape Analysis

    • 9.1 Asia Pacific mRNA Vaccines and Therapeutics Landscape Analysis by Major Types

    • 9.2 Asia Pacific mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific mRNA Vaccines and Therapeutics Landscape Analysis by Major Countries

      • 9.3.1 China mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 9.3.2 Japan mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 9.3.4 India mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 9.3.6 South Korea mRNA Vaccines and Therapeutics Market Volume and Growth Rate

    10 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 10.3.2 Brazil mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 10.3.3 Nigeria mRNA Vaccines and Therapeutics Market Volume and Growth Rate

      • 10.3.4 South Africa mRNA Vaccines and Therapeutics Market Volume and Growth Rate 

      • 10.3.5 Argentina mRNA Vaccines and Therapeutics Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 BioNtech

      • 11.1.1 BioNtech Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 eTheRNA immunotherapies

      • 11.2.1 eTheRNA immunotherapies Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 BioNTech

      • 11.3.1 BioNTech Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Bayer

      • 11.4.1 Bayer Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Janssen

      • 11.5.1 Janssen Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 In-Cell-Art

      • 11.6.1 In-Cell-Art Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 MaxCyte

      • 11.7.1 MaxCyte Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 CRISPR Therapeutics

      • 11.8.1 CRISPR Therapeutics Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 PhaseRx

      • 11.9.1 PhaseRx Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Kernal Biologics

      • 11.10.1 Kernal Biologics Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Novartis

      • 11.11.1 Novartis Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Precision NanoSystems

      • 11.12.1 Precision NanoSystems Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 RaNa Therapeutics

      • 11.13.1 RaNa Therapeutics Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 CureVac

      • 11.14.1 CureVac Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Bayer Group Therapeutics

      • 11.15.1 Bayer Group Therapeutics Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Crispr Therapeutics

      • 11.16.1 Crispr Therapeutics Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 AstraZeneca

      • 11.17.1 AstraZeneca Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Argos Therapeutics

      • 11.18.1 Argos Therapeutics Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 AstraZeneca Plc Vaccines

      • 11.19.1 AstraZeneca Plc Vaccines Company Profile and Development Status

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Ethris

      • 11.20.1 Ethris Company Profile and Development Status

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 96 Figures and 151 Tables)

    • Figure Product Picture

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine from 2014 to 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Individualized Cancer Treatment mRNA Vaccine from 2014 to 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infectious Disease Treatment mRNA Vaccine from 2014 to 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Infection Prevention mRNA Vaccine from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Global mRNA Vaccines and Therapeutics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina mRNA Vaccines and Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of mRNA Vaccines and Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of mRNA Vaccines and Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of mRNA Vaccines and Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines and Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine

    • Figure Market Size and Growth Rate of Individualized Cancer Treatment mRNA Vaccine

    • Figure Market Size and Growth Rate of Infectious Disease Treatment mRNA Vaccine

    • Figure Market Size and Growth Rate of Infection Prevention mRNA Vaccine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of mRNA Vaccines and Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of mRNA Vaccines and Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Other

    • Table Global mRNA Vaccines and Therapeutics Production by Major Regions

    • Table Global mRNA Vaccines and Therapeutics Production Share by Major Regions

    • Figure Global mRNA Vaccines and Therapeutics Production Share by Major Regions in 2014

    • Figure Global mRNA Vaccines and Therapeutics Production Share by Major Regions in 2018

    • Figure Global mRNA Vaccines and Therapeutics Production Share by Major Regions in 2026

    • Table Global mRNA Vaccines and Therapeutics Consumption by Major Regions

    • Table Global mRNA Vaccines and Therapeutics Consumption Share by Major Regions

    • Figure Global mRNA Vaccines and Therapeutics Consumption Share by Major Regions in 2014

    • Figure Global mRNA Vaccines and Therapeutics Consumption Share by Major Regions in 2018

    • Figure Global mRNA Vaccines and Therapeutics Consumption Share by Major Regions in 2026

    • Table North America mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in mRNA Vaccines and Therapeutics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America mRNA Vaccines and Therapeutics Consumption by Types from 2014 to 2026

    • Table North America mRNA Vaccines and Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Types in 2014

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Types in 2018

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Types in 2026

    • Table North America mRNA Vaccines and Therapeutics Consumption by End-Users from 2014 to 2026

    • Table North America mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2014

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2018

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2026

    • Table North America mRNA Vaccines and Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America mRNA Vaccines and Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Types in 2014

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Types in 2018

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Types in 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2014

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2018

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe mRNA Vaccines and Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2014

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2018

    • Figure Europe mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2026

    • Figure Germany mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption by Types from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Types in 2014

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Types in 2018

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Types in 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2014

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2018

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2026

    • Figure China mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandmRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa mRNA Vaccines and Therapeutics Consumption Share by Major Countries in 2026

    • Figure GCC Countries mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina mRNA Vaccines and Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of BioNtech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNtech

    • Figure Sales and Growth Rate Analysis of BioNtech

    • Figure Revenue and Market Share Analysis of BioNtech

    • Table Product and Service Introduction of BioNtech

    • Table Company Profile and Development Status of eTheRNA immunotherapies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA immunotherapies

    • Figure Sales and Growth Rate Analysis of eTheRNA immunotherapies

    • Figure Revenue and Market Share Analysis of eTheRNA immunotherapies

    • Table Product and Service Introduction of eTheRNA immunotherapies

    • Table Company Profile and Development Status of BioNTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech

    • Figure Sales and Growth Rate Analysis of BioNTech

    • Figure Revenue and Market Share Analysis of BioNTech

    • Table Product and Service Introduction of BioNTech

    • Table Company Profile and Development Status of Bayer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of In-Cell-Art

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art

    • Figure Sales and Growth Rate Analysis of In-Cell-Art

    • Figure Revenue and Market Share Analysis of In-Cell-Art

    • Table Product and Service Introduction of In-Cell-Art

    • Table Company Profile and Development Status of MaxCyte

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MaxCyte

    • Figure Sales and Growth Rate Analysis of MaxCyte

    • Figure Revenue and Market Share Analysis of MaxCyte

    • Table Product and Service Introduction of MaxCyte

    • Table Company Profile and Development Status of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Company Profile and Development Status of PhaseRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PhaseRx

    • Figure Sales and Growth Rate Analysis of PhaseRx

    • Figure Revenue and Market Share Analysis of PhaseRx

    • Table Product and Service Introduction of PhaseRx

    • Table Company Profile and Development Status of Kernal Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kernal Biologics

    • Figure Sales and Growth Rate Analysis of Kernal Biologics

    • Figure Revenue and Market Share Analysis of Kernal Biologics

    • Table Product and Service Introduction of Kernal Biologics

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Precision NanoSystems

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Precision NanoSystems

    • Figure Sales and Growth Rate Analysis of Precision NanoSystems

    • Figure Revenue and Market Share Analysis of Precision NanoSystems

    • Table Product and Service Introduction of Precision NanoSystems

    • Table Company Profile and Development Status of RaNa Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of RaNa Therapeutics

    • Figure Sales and Growth Rate Analysis of RaNa Therapeutics

    • Figure Revenue and Market Share Analysis of RaNa Therapeutics

    • Table Product and Service Introduction of RaNa Therapeutics

    • Table Company Profile and Development Status of CureVac

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac

    • Figure Sales and Growth Rate Analysis of CureVac

    • Figure Revenue and Market Share Analysis of CureVac

    • Table Product and Service Introduction of CureVac

    • Table Company Profile and Development Status of Bayer Group Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Group Therapeutics

    • Figure Sales and Growth Rate Analysis of Bayer Group Therapeutics

    • Figure Revenue and Market Share Analysis of Bayer Group Therapeutics

    • Table Product and Service Introduction of Bayer Group Therapeutics

    • Table Company Profile and Development Status of Crispr Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Crispr Therapeutics

    • Figure Sales and Growth Rate Analysis of Crispr Therapeutics

    • Figure Revenue and Market Share Analysis of Crispr Therapeutics

    • Table Product and Service Introduction of Crispr Therapeutics

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Argos Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics

    • Figure Sales and Growth Rate Analysis of Argos Therapeutics

    • Figure Revenue and Market Share Analysis of Argos Therapeutics

    • Table Product and Service Introduction of Argos Therapeutics

    • Table Company Profile and Development Status of AstraZeneca Plc Vaccines

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Plc Vaccines

    • Figure Sales and Growth Rate Analysis of AstraZeneca Plc Vaccines

    • Figure Revenue and Market Share Analysis of AstraZeneca Plc Vaccines

    • Table Product and Service Introduction of AstraZeneca Plc Vaccines

    • Table Company Profile and Development Status of Ethris

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris

    • Figure Sales and Growth Rate Analysis of Ethris

    • Figure Revenue and Market Share Analysis of Ethris

    • Table Product and Service Introduction of Ethris


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US